ALS is life‑changing, but new treatments, specialized care, and innovative research are bringing real hope. See how advances at University of Utah Health are shaping the future of ALS care.

See her inspiring message to the Kansas City Royals ahead of their home opener at The K.

ALS remains a devastating neurodegenerative condition with limited treatments, but increasing clinical trial activity worldwide reflects growing scientific confidence that new therapeutic strategies ...

Scientists in Sunnybrook’s Hurvitz Brain Sciences Program recently made history as they non-invasively opened the blood-brain barrier (BBB) to deliver a small dose of immunotherapy directly to the ...

The ALS therapy candidate AP-101 significantly extended patient survival and delayed the need for respiratory support in a ...

The University of Southern Indiana hosted an event aimed at raising awareness for ALS. The event was called Illuminate ALS.

An experimental oral therapy was well-tolerated and linked to lower risks for ALS complications, according to findings of a phase 2b randomized controlled trial published in JAMA Neurology.“The ...

Former Premier League footballer Petter Rudi diagnosed with ALS - Petter Rudi played in the Premier League for Sheffield ...

Elon Musk highlights Neuralink’s latest breakthrough as ALS patient Kenneth Shock regains ability to communicate. The brain ...

NAARDEN, The Netherlands & WALTHAM, Mass. & BARCELONA, Spain, March 30, 2026--Prilenia Therapeutics B.V. and Ferrerii today announced the first enrollment in the pivotal, 500-participant, randomized, ...

A new gene therapy, Celosia's CTx1000, is now being tested for ALS in a small clinical trial in Australia. The one-time treatment targets toxic TDP-43 protein clumps, a key driver of most cases of ALS ...